Acurx Pharmaceuticals (ACXP) Tops Q1 EPS by 27c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.11), $0.27 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
• Blue Owl Capital (OWL) spreader of 50K contracts of August 12 and November 11 puts as share price down 2%
• Etsy upgraded to buy at BofA on durable growth, buyback potential